![Anthony Polverino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony Polverino
Direttore/Membro del Consiglio presso BRAINSTORM CELL THERAPEUTICS INC.
Patrimonio netto: 12 643 $ in data 31/05/2024
Profilo
Dr. Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He is on the Board of Directors at Brainstorm Cell Therapeutics, Inc. Dr. Polverino was previously employed as a Chief Scientific Officer & EVP-Early Development by Zymeworks BC, Inc., a Chief Scientific Officer by Kite Pharma, Inc., and an Executive Director-Therapeutic Innovation Unit by Amgen, Inc. He received his undergraduate degree from the University of Adelaide and a doctorate degree from Flinders University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/03/2024 | 25 960 ( 0.04% ) | 12 643 $ | 31/05/2024 |
Posizioni attive di Anthony Polverino
Società | Posizione | Inizio |
---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 05/02/2018 |
Precedenti posizioni note di Anthony Polverino
Società | Posizione | Fine |
---|---|---|
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Direttore Tecnico/Scientifico/R&S | 19/01/2022 |
KITE PHARMA INC | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Anthony Polverino
University of Adelaide | Undergraduate Degree |
Flinders University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
AMGEN INC. | Health Technology |
Aziende private | 2 |
---|---|
Kite Pharma, Inc.
![]() Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Anthony Polverino